Trials / Sponsors / Juan LI, MD
Juan LI, MD
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mut Non Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation | Phase 2 | 2023-12-31 |
| Unknown | Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC Stage III Non-small Cell Lung Cancer | Phase 1 | 2021-06-10 |